Global Deferiprone Market Infographics Description:
- The Global Deferiprone Market is estimated at US$ 35.2 Mn in 2020.
- Worldwide Deferiprone Market is projected to reach US$ 37.8 Mn in 2028 at a CAGR of 0.9% from 2021 to 2028.
- Among all the formulation segments, the oral solution is expected to register the highest CAGR of over 1.3%, while the tаblеt ѕеgmеnt ассоuntѕ fоr thе mајоrіtу ѕhаrе іn thе Global Deferiprone Market
- Amongst indiaction segments, the transfusional iron overload segment in the global deferiprone market is estimated to account for a majority revenue share of 79.1% in 2020 end.
- United States market is expected to dominate the Global Deferiprone Market owing to the presence of key market players in this region. It is expected to account for the largest market revenue share as compared to that of markets in other regions.
- Companies profiled in the report are Cipla Limited., Apotex Inc., Swedish Orphan Biovitrum AB (publ)., Genepharm S.A., Lipomed AG., Drug International Limited., Ambrosia Remedies (P) Ltd., and Focus Pharmaceuticals Limited.
